Synthesis and biological activity of 1-methyl-tryptophan-tirapazamine hybrids as hypoxia-targeting indoleamine 2,3-dioxygenase inhibitors.

Synthesis and biological activity of 1-methyl-tryptophan-tirapazamine hybrids as hypoxia-targeting indoleamine 2,3-dioxygenase inhibitors.
复制标题

DOI:
10.1016/j.bmc.2008.07.087
复制
发表时间:
2008-09
影响因子:
3.5
通讯作者:
H. Nakashima;Y. Uto;Eiji Nakata;H. Nagasawa;Kazuhiro Ikkyu;N. Hiraoka;K. Nakashima;Yuki Sasaki;H. Sugimoto;Y. Shiro;T. Hashimoto;Y. Okamoto;Y. Asakawa;H. Hori
H. Nakashima;Y. Uto;Eiji Nakata;H. Nagasawa;Kazuhiro Ikkyu;N. Hiraoka;K. Nakashima;Yuki Sasaki;H. Sugimoto;Y. Shiro;T. Hashimoto;Y. Okamoto;Y. Asakawa;H. Hori
中科院分区:
医学3区
文献类型:
--
作者:
H. Nakashima;Y. Uto;Eiji Nakata;H. Nagasawa;Kazuhiro Ikkyu;N. Hiraoka;K. Nakashima;Yuki Sasaki;H. Sugimoto;Y. Shiro;T. Hashimoto;Y. Okamoto;Y. Asakawa;H. Hori

文献摘要

被引文献

相似文献

我们已经设计并合成了新的缺氧肿瘤细胞靶向吲哚胺2,3-双加氧酶(IDO)抑制剂。制备了1-甲基色氨酸(1 MT)-替拉扎明(TPZ,3-氨基-1,2,4-苯并三嗪1,4-二氧化物)杂合抑制剂,包括1(TX-2236)、2(TX-2235)、3(TX-2228)和4(TX-2234)。所有这些化合物都是非竞争性IDO抑制剂。TPZ-一氧化物杂合体1和3显示出比TPZ杂合体2和4更高的IDO抑制活性。在这些杂交体中,杂交体1是最有效的IDO抑制剂。TPZ杂合体2和4对EMT 6/KU细胞的缺氧选择性细胞毒作用强于TPZ。这些数据表明TPZ杂合物2和4可能通过其双重生物学功能起作用:首先,它们在缺氧细胞中充当缺氧细胞毒素,然后代谢成其TPZ-一氧化物(3-氨基-1,2,4-苯并三嗪1-氧化物)杂合物,其充当IDO抑制剂。
We have designed and synthesized new hypoxic-neoplastic cells-targeted indoleamine 2,3-dioxygenase (IDO) inhibitors. 1-Methyl-tryptophan (1MT)-tirapazamine (TPZ, 3-amino-1,2,4-benzotriazine 1,4-dioxide) hybrid inhibitors including 1 (TX-2236), 2 (TX-2235), 3 (TX-2228), and 4 (TX-2234) were prepared. All of these compounds were uncompetitive IDO inhibitors. TPZ-monoxide hybrids 1 and 3 showed higher IDO inhibitory activities than TPZ hybrids 2 and 4. Among these hybrids, hybrid 1 was the most potent IDO inhibitor. TPZ hybrids 2 and 4 showed stronger hypoxia-selective cytotoxicity than TPZ to EMT6/KU cells. These data suggest that TPZ hybrids 2 and 4 may act through their dual biological functions: first, they function as hypoxic cytotoxins in hypoxic cells, and then are metabolized to their TPZ-monoxide (3-amino-1,2,4-benzotriazine 1-oxide) hybrids, which function as IDO inhibitors.